Clinical trial
Effect of Intravitreal Bevacizumab on Non -Age-Related Macular Degeneration…
NCT00370786 · Shahid Beheshti University of Medical Sciences, Other · Completed
Key facts
| NCT number | NCT00370786 |
|---|---|
| Title | Effect of Intravitreal Bevacizumab on Non -Age-Related Macular Degeneration (AMD) Related Choroidal Neovascularization (CNV) |
| Lead sponsor | Shahid Beheshti University of Medical Sciences, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Choroidal Neovascularization |
| Intervention type | Drug |
| Interventions | bevacizumab |
| Enrollment | 31 |
| Start date | Nov 1, 2005 |
| Primary completion | Nov 1, 2007 |
| Completion | Feb 1, 2008 |
| First posted | Sep 1, 2006 |
| Last update posted | Jul 11, 2008 |
| Countries | Iran |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: